Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2022). On theSindex it has a DataRank of 1.2. It has been cited 24 times, with 21 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.483
From this paper's citation signal
Citation Network Contribution
0.679
From 18 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 21 citers.
AstraZeneca
Chiesi Farmaceutici
Teva Pharmaceutical Industries
Boehringer Ingelheim
Genentech
GlaxoSmithKline
Merck Sharp and Dohme
Novartis
Sanofi-Aventis Deutschland
Merck
Schering-Plough
Shionogi
American Lung Association
National Institutes of Health
MeSH Terms
Keywords